Dr Agarwal’s Health Care IPO listing today. Check GMP ahead of the debut

Dr Agarwal’s Health Care’s upcoming listing worries investors due to a discounted grey market premium and muted subscription. Despite being India’s largest eye care chain, with a 25% market share in FY24, and significant revenue and efficiency growth, market conditions appear challenging. Analysts recommend a long-term investment view for potential gains. Dr Agarwal’s Health Care’s upcoming listing worries investors due to a discounted grey market premium and muted subscription. Despite being India’s largest eye care chain, with a 25% market share in FY24, and significant revenue and efficiency growth, market conditions appear challenging. Analysts recommend a long-term investment view for potential gains.  Economic Times